[1]
Żarowski M., Zgorzalewicz M.,Steinborn B.: Zespół Klippela-Trenaunaya
- opis przypadku. Neurol Dziec 2004; 13: 51–54.
[2]
Wassef M., Blei F., Adams D., et al.: Vascular Anomalies Classification:
Recommendations From the International Society for the Study of
Vascular Anomalies. Pediatrics 2015; 136: 203–214.
[3]
Falkowski A., Miernik M., Cnotliwy M., et al.: Zespół Klippel-Trenaunay
– problem diagnostyczny i leczniczy. Polish Journal of Radiology 2002;
67: 45–47.
[4]
Jacob A.G., Driscoll D.J., Shaughnessy W.J., et al.: Klippel-Trenaunay
syndrome: spectrum and management. Mayo Clin Proc 1998; 73: 28–36.
[5]
Volz K.R., Kanner C.D., Evans J., et al.: Klippel-Trenaunay Syndrome:
Need for Careful Clinical Classification. J Ultrasound Med 2016; 35:
2057–2065.
[6]
Jones K.L., Jones M.C., Campo M.D.: Smith’s recognizable patterns of
human malformation 7th. Elsevier Saunders, Philadelphia 2013.
[7]
Goldstein S.J., Lee C., Young A.B., et al.: Aplasia of the cervical internal
carotid artery and malformation of the circle of Willis associated with
Klippel-Trenaunay syndrome. Case report. J Neurosurg 1984; 61: 786–
789.
[8]
Redondo P., Bastarrika G., Sierra A., et al.: Efficacy and safety of
microfoam sclerotherapy in a patient with Klippel-Trenaunay syndrome
and a patent foramen ovale. Arch Dermatol 2009; 145: 1147–1151.
[9]
Bergan J., Pascarella L., Mekenas L.: Venous disorders: treatment with
sclerosant foam. J Cardiovasc Surg (Torino) 2006; 47: 9–18.
[10]
Renard D., Campello C., Taieb G., et al.: Neurologic and vascular
abnormalities in Klippel-Trenaunay-Weber syndrome. JAMA Neurol
2013; 70: 127–128.
[11]
Mokri B.: Klippel-Trenaunay-Weber syndrome (KTWS) and spontaneous
spinal CSF leak: coincidence or link. Headache 2014; 54: 726–731.
[12]
Beume L.A., Fuhrmann S.C., Reinhard M., et al.: Coincidence of
ischemic stroke and recurrent brain haemorrhage in a patient with
Klippel-Trenaunay Syndrome. J Clin Neurosci 2013; 20: 1454–1455.
[13]
Renard D., Larue A., Taieb G., et al.: Recurrent cerebral infarction in
Klippel-Trenaunay-Weber syndrome. Clin Neurol Neurosurg 2012; 114:
1019–1020.
[14]
Kentab A.Y.: Klippel-Trenaunay and Sturge-Weber overlapping
syndrome in a Saudi boy. Sudan J Paediatr 2016; 16: 86–92.
[15]
Howes J.A., Setty G., Khan A., et al.: A rare paediatric case of Klippel-
Trenaunay-Weber syndrome. J Pediatr Neurosci 2015; 10: 87–88.
[16]
Demir C.F., Yildiz M., Ozdemir H., et al.: Paraplegia in pregnancy: a case
of spinal vascular malformation with Klippel-Trenaunay syndrome.
Spine (Phila Pa 1976) 2012; 37: 1218–1220.
[17]
Yazaki M., Kaneko K., Tojo K., et al.: An unusual case of Klippel-
Trenaunay-Weber syndrome presenting with portosystemic
encephalopathy. Intern Med 2008; 47: 1621–1625.
[18]
Verhelst H.,Van Coster R.: Neuroradiologic findings in a young patient
with characteristics of Sturge-Weber syndrome and Klippel-Trenaunay
syndrome. J Child Neurol 2005; 20: 911–913.
[19]
Torregrosa A., Marti-Bonmati L., Higueras V., et al.: Klippel-Trenaunay
syndrome: frequency of cerebral and cerebellar hemihypertrophy on
MRI. Neuroradiology 2000; 42: 420–423.
[20]
Vahidnezhad H., Youssefian L., Uitto J.: Klippel-Trenaunay syndrome
belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp
Dermatol 2016; 25: 17–19.
[21]
Headache Classification Committee of the International Headache S.:
The International Classification of Headache Disorders, 3rd edition
(beta version). Cephalalgia 2013; 33: 629–808.
[22]
Aromaa M., Rautava P., Sillanpaa M., et al.: Familial occurrence of
headache. Cephalalgia 1999; 25: 49–52.
[23]
Russell M.B., Ostergaard S., Bendtsen L., et al.: Familial occurrence of
chronic tension-type headache. Cephalalgia 1999; 19: 207–210.
[24]
Anttila P., Metsahonkala L., Sillanpaa M.: School start and occurrence
of headache. Pediatrics 1999; 103: 80.
[25]
Nachit-Ouinekh F., Chrysostome V., Henry P., et al.: Variability of
reported headache symptoms and diagnosis of migraine at 12 months.
Cephalalgia 2005; 25: 117–123.
[26]
Craven N., Wright A.L.: Familial Klippel-Trenaunay syndrome: a case
report. Clin Exp Dermatol 1995; 20: 76–79.
[27]
Lee A., Driscoll D., Gloviczki P., et al.: Evaluation and management of
pain in patients with Klippel-Trenaunay syndrome: a review. Pediatrics
2005; 115: 744–749.
[28]
Lorda-Sanchez I., Prieto L., Rodriguez-Pinilla E., et al.: Increased
parental age and number of pregnancies in Klippel-Trenaunay-Weber
syndrome. Ann Hum Genet 1998; 62: 235–239.
[29]
Dimopoulos A., Sicko R.J., Kay D.M., et al.: Copy number variants in
a population-based investigation of Klippel-Trenaunay syndrome. Am J
Med Genet A 2017; 173: 352–359.
[30]
Zhang T., Yao Y., Wang J., et al.: Haploinsufficiency of Klippel-Trenaunay
syndrome gene Aggf1 inhibits developmental and pathological
angiogenesis by inactivating PI3K and AKT and disrupts vascular
integrity by activating VE-cadherin. Hum Mol Genet 2016; 25: 5094–
5110.
[31]
Timur A.A., Sadgephour A., Graf M., et al.: Identification and molecular
characterization of a de novo supernumerary ring chromosome 18 in
a patient with Klippel-Trenaunay syndrome. Ann Hum Genet 2004; 68:
353–361.
[32]
Tian X.L., Kadaba R., You S.A., et al.: Identification of an angiogenic
factor that when mutated causes susceptibility to Klippel-Trenaunay
syndrome. Nature 2004; 427: 640–645.
[33]
Gutierrez S., Magano L., Delicado A., et al.: The G397A (E133K) change
in the AGGF1 (VG5Q) gene is a single nucleotide polymorphism in the
Spanish population. Am J Med Genet A 2006; 140: 2832–2833.
[34]
Barker K.T., Foulkes W.D., Schwartz C.E., et al.: Is the E133K allele
of VG5Q associated with Klippel-Trenaunay and other overgrowth
syndromes? J Med Genet 2006; 43: 613–614.
[35]
Luks V.L., Kamitaki N., Vivero M.P., et al.: Lymphatic and other vascular
malformative/overgrowth disorders are caused by somatic mutations
in PIK3CA. J Pediatr 2015; 166: 1048–1054.
[36]
Frieden I.J.,H Chu D.: Klippel-Trenaunay syndrome: Clinical manifestations,
diagnosis, and management. 2016, Address: www.uptodate.com/
contents/klippel-trenaunay-syndrome-clinical-manifestations-diagnosis-and-management?source=search_result&search=klippel%20trenaunay%
20syndrome&selectedTitle=1~74.
[37]
Ogrodnik M., Sadowski K., Jóźwiak S.: Neurological manifestations of
Proteus syndrome – review of the literature. Neurol Dziec 2015; 24:
47–53.
[38]
Nguyen D., Turner J.T., Olsen C., et al.: Cutaneous manifestations of
proteus syndrome: correlations with general clinical severity. Arch
Dermatol 2004; 140: 947–953.
[39]
Lee M.S., Liang M.G., Mulliken J.B.: Diffuse capillary malformation with
overgrowth: a clinical subtype of vascular anomalies with hypertrophy.
J Am Acad Dermatol 2013; 69: 589–594.
[40]
Gloviczki P., Driscoll D.J.: Klippel-Trenaunay syndrome: current
management. Phlebology 2007; 22: 291–298.
[41]
Nguyen J.T., Koerper M.A., Hess C.P., et al.: Aspirin therapy in venous
malformation: a retrospective cohort study of benefits, side effects,
and patient experiences. Pediatr Dermatol 2014; 31: 556–560.
[42]
Enjolras O., Chapot R.,Merland J.J.: Vascular anomalies and the growth
of limbs: a review. J Pediatr Orthop B 2004; 13: 349–357.
[43]
Sabharwal S., Kumar A.: Methods for assessing leg length discrepancy.
Clin Orthop Relat Res 2008; 466: 2910–2922.
[44]
Baskerville P.A., Ackroyd J.S., Lea Thomas M., et al.: The Klippel-
Trenaunay syndrome: clinical, radiological and haemodynamic features
and management. Br J Surg 1985; 72: 232–236.
[45]
Adams D.M., Trenor C.C., 3rd, Hammill A.M., et al.: Efficacy and Safety
of Sirolimus in the Treatment of Complicated Vascular Anomalies.
Pediatrics 2016; 137: e20153257.
[46]
Sermsathanasawadi N., Hongku K., Wongwanit C., et al.: Endovenous
radiofrequency thermal ablation and ultrasound-guided foam
sclerotherapy in treatment of klippel-trenaunay syndrome. Ann Vasc
Dis 2014; 7: 52–55.
[47]
Gloviczki P., Stanson A.W., Stickler G.B., et al.: Klippel-Trenaunay
syndrome: the risks and benefits of vascular interventions. Surgery
1991; 110: 469–479.
[48]
Burrows P.E., Mason K.P.: Percutaneous treatment of low flow vascular
malformations. J Vasc Interv Radiol 2004; 15: 431–445.
[49]
Malgor R.D., Gloviczki P., Fahrni J., et al.: Surgical treatment of varicose
veins and venous malformations in Klippel-Trenaunay syndrome.
Phlebology 2016; 31: 209–215.
[50]
Kern S., Niemeyer C., Darge K., et al.: Differentiation of vascular
birthmarks by MR imaging. An investigation of hemangiomas, venous
and lymphatic malformations. Acta Radiol 2000; 41: 453–457.
Adres do korespondencji:
Jędrzej Fliciński, Katedra i Klinika Neurologii Wieku Rozwojowego, Uniwersytet Medyczny im. Karola Marcinkowskiego Poznaniu, ul. Przybyszewskiego 49
Poznań 60-355, e-mail: flicinski@ump.edu.pl
[51]
Oduber C.E., van Beers E.J., Bresser P., et al.: Venous thromboembolism
and prothrombotic parameters in Klippel-Trenaunay syndrome. Neth J
Med 2013; 71: 246–252.
[52]
Douma R.A., Oduber C.E., Gerdes V.E., et al.: Chronic pulmonary
embolism in Klippel-Trenaunay syndrome. J Am Acad Dermatol 2012;
66: 71–77.
Scholar Google
PubMed